Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jamie, Randall"'
Autor:
Laura E. Johnston, Jamie Randall, Safae Chouraichi, Mary Luu, Allison L. Hunt, Lauren Mauro, Claudius Mueller, Justin B. Davis, Emanuel F. Petricoin, Thomas P. Conrads, Timothy L. Cannon, Jasmine Huynh
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-7 (2024)
Abstract Recent trials have shown the efficacy of trastuzumab deruxtecan (T-DXd) in HER2-negative patients, but there is not yet a way to identify which patients will best respond, especially with the inability of current HER2 IHC and FISH assays to
Externí odkaz:
https://doaj.org/article/62cf1a759ec3482aa0239484568040b5
Autor:
Allison L Hunt, Aratara Nutcharoen, Jamie Randall, Alyssa Papazian, John Deeken, G Larry Maxwell, Nicholas W Bateman, Emanuel F Petricoin, Amin Benyounes, Thomas P Conrads, Timothy L Cannon
Publikováno v:
The Oncologist.
Inflammatory myofibroblastic tumors (IMTs) are intermediate-grade mesenchymal neoplasms commonly characterized by chromosomal rearrangements causing constitutive activation of anaplastic lymphoma kinase (ALK) and/or ALK mutations causing reduced sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74656ef3aab8bc311fcd1613bc3d43b6
https://doi.org/10.1093/oncolo/oyad129
https://doi.org/10.1093/oncolo/oyad129
Publikováno v:
Journal of Clinical Oncology. 40:103-103
103 Background: Disparities in cancer care due to race and ethnicity are prevalent in both the care patients receive and patient outcomes. The evaluation of next generation sequencing (NGS) results from patients with advanced cancer by a molecular tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f417026215045d66afb8732f78399f97
https://doi.org/10.1200/jco.2022.40.28_suppl.103
https://doi.org/10.1200/jco.2022.40.28_suppl.103
Autor:
Timothy Lewis, Cannon, Laura, Knopp, Hongkun, Wang, Tiffani, DeMarco, John Milburn, Jessup, Jamie, Randall, Erica, Kim, Donald L, Trump
Publikováno v:
Current Problems in Cancer. 46:100860
Patient engagement in medical decision-making improves patient related outcomes through compliance and patient satisfaction. The Inova Schar Cancer Institute has a weekly molecular tumor board (MTB) to match comprehensive genomic sequencing results w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bc41b9998d48e196eafb56c0f560e4
https://doi.org/10.1016/j.currproblcancer.2022.100860
https://doi.org/10.1016/j.currproblcancer.2022.100860
Publikováno v:
Journal of Clinical Oncology. 40:e16259-e16259
e16259 Background: Advanced PDAC is associated with a poor prognosis and median survivals of less than one year. FOLFIRINOX and Gemcitabine/Nab-Paclitaxel are both considered standard of care in the first line setting, though there is considerable va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::829d0d1da8f146102ccc6735b6d989a9
https://doi.org/10.1200/jco.2022.40.16_suppl.e16259
https://doi.org/10.1200/jco.2022.40.16_suppl.e16259
Autor:
Rakesh Biswas, Tiffani DeMarco, Arthur Winer, Raymond Couric Wadlow, Jamie Randall, Misha Rashkin, Rhianna Urban, Timothy Lewis Cannon
Publikováno v:
Journal of Clinical Oncology. 40:10581-10581
10581 Background: MSI-H colorectal cancer is most often a result of deleterious mutations in mismatch repair genes, but can also occur through repressed gene transcription due to hypermethylation of the MLH1 promoter, often associated with BRAF V600E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e49507bf4032fa855d79dde10e163b0
https://doi.org/10.1200/jco.2022.40.16_suppl.10581
https://doi.org/10.1200/jco.2022.40.16_suppl.10581
Autor:
Ethan Sokol, Raymond C. Wadlow, Timothy L. Cannon, Halla Nimeiri, Jamie Randall, John F. Deeken, Sonja Alexander, Daniel Barnett, Danny Rayes, Kimberly McGregor
Publikováno v:
Journal of Clinical Oncology. 39:3561-3561
3561 Background: BRAF V600E+, MSS mCRC patients comprise up to 10% of advanced CRC. They have a poor prognosis with median survivals typically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6535dc83a941fd2efab912f031e97e0f
https://doi.org/10.1200/jco.2021.39.15_suppl.3561
https://doi.org/10.1200/jco.2021.39.15_suppl.3561
Autor:
Dan Barnett, Jamie Randall, Sarah Mullaly, Gail Payne, Erica Marchlik, Sheryl Krevsky Elkin, Danny Rayes, Hongkun Wang, Raymond C. Wadlow, Lindsey Tishman, Timothy L. Cannon
Publikováno v:
Journal of Clinical Oncology. 39:129-129
129 Background: KRAS and NRAS (RAS) mutations are considered driver mutations in gastrointestinal malignancies such as colorectal and pancreatic cancer. Our institution obtains broad molecular testing (commercial panels with full exon coverage of at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9efe756b61a0ee4206ca4ad621b3b26b
https://doi.org/10.1200/jco.2021.39.3_suppl.129
https://doi.org/10.1200/jco.2021.39.3_suppl.129
Publikováno v:
Journal of Ecotourism; Mar2013, Vol. 12 Issue 1, p33-48, 16p